Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.
Autorzy:
Nguyen HG; Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA. Yang JC; Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA. Kung HJ; 1] Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA, USA [2] UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, CA, USA. Shi XB; Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA. Tilki D; Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA. Lara PN Jr; UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, CA, USA. DeVereWhiteRW; 1] Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA [2] UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, CA, USA. Gao AC; 1] Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA [2] UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, CA, USA. Evans CP; 1] Department of Urology, UC Davis School of Medicine, Sacramento, CA, USA [2] UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Sacramento, CA, USA.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2014 Sep 04; Vol. 33 (36), pp. 4521-30. Date of Electronic Publication: 2014 Mar 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
Autorzy:
Kao CJ; Department of Biochemistry and Molecular Medicine, University of California-Davis, Davis, CA, USA. Martiniez A; Department of Biochemistry and Molecular Medicine, University of California-Davis, Davis, CA, USA. Shi XB; Department of Urology, University of California-Davis, Sacramento, CA, USA. Yang J; Department of Urology, University of California-Davis, Sacramento, CA, USA. Evans CP; Department of Urology, University of California-Davis, Sacramento, CA, USA. Dobi A; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD, USA. deVereWhiteRW; Department of Urology, University of California-Davis, Sacramento, CA, USA. Kung HJ; 1] Department of Biochemistry and Molecular Medicine, University of California-Davis, Davis, CA, USA [2] Institute of Molecular and Genomic Medicine, National Health Research Institutes, Maioli, Taiwan [3] Translational Medicine and Integrated Lab, Taipei Medical University, Taipei, Taiwan.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2014 May 08; Vol. 33 (19), pp. 2495-503. Date of Electronic Publication: 2013 Jun 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies